Home > Search Results: Roberts, Irene
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 2 records in 0.01 seconds.
Articles, 2 records found
Articles 2 records found  
1.
12 p, 4.8 MB Down syndrome and leukemia : from basic mechanisms to clinical advances / Baruchel, André (Hôpital Universitaire Robert Debré, Paris, France) ; Bourquin, Jean Pierre (University Children's Hospital, Zurich, Switzerland) ; Crispino, John (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Cuartero, Sergi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hasle, Henrik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Hitzler, Johann (The Hospital for Sick Children, Toronto, Canada) ; Klusmann, Jan Henning (Goethe University Frankfurt, Germany) ; Izraeli, Shai (Tel Aviv University, Tel Aviv, Israel) ; Lane, Andrew A. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Malinge, Sebastien (Cancer Centre, Perth, Western Australia) ; Rabin, Karen R. (University of Oxford, UK) ; Roberts, Irene (University of Oxford, UK) ; Ryeom, Sandra (Columbia University Irving Medical Center, New York, USA) ; Tasian, Sarah K. (University of Pennsylvania Perelman School of Medicine, Philadelphia, USA) ; Wagenblast, Elvin (Icahn School of Medicine at Mount Sinai, New York, USA)
Children with Down syndrome (DS, trisomy 21) are at a significantly higher risk of developing acute leukemia compared to the overall population. Many studies investigating the link between trisomy 21 and leukemia initiation and progression have been conducted over the last two decades. [...]
2023 - 10.3324/haematol.2023.283225
Haematologica, Vol. 108 Núm. 10 (october 2023) , p. 2570-2581  
Detailed record - Creative Commons
2.
14 p, 1.0 MB CD34 + CD19 − CD22 + B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies / Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Barrera, Susana (Universidad de Salamanca) ; Bataller, Alex (Hospital Clínic i Provincial de Barcelona) ; Ortiz-Maldonado, Valentín (Hospital Clínic i Provincial de Barcelona) ; Elliot, Natalina (John Radcliffe Hospital (Oxford, Regne Unit)) ; O'Byrne, Sorcha (John Radcliffe Hospital (Oxford, Regne Unit)) ; Wang, Guanlin (University of Oxford) ; Rovira, Montse (University of Oxford) ; Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Trincado Alonso, Juan Luis, 1987- (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; González-González, María (Universidad de Salamanca) ; Morgades, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sorigue, Marc (Universitat Autònoma de Barcelona) ; Bárcena, Paloma (Universidad de Salamanca) ; Zanetti, S. R (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Torrebadell, Montse (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Vega-Garcia, Nerea (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Rives, Susana (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Mallo, Maria del Mar (Universitat Autònoma de Barcelona) ; Sole, F (Universitat Autònoma de Barcelona) ; Mead, Adam J. (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; Roberts, Irene (Oxford Biomedical Research Centre) ; Thongjuea, Supat (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Psaila, Bethan (Oxford Biomedical Research Centre) ; Juan, Manel (Hospital Clínic i Provincial de Barcelona) ; Delgado, Julio (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Urbano-Ispizúa, Alvaro (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribera, Jose-Maria (Universitat Autònoma de Barcelona) ; Orfao, Alberto (Universidad de Salamanca) ; Roy, Anindita (Oxford Biomedical Research Centre) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Three article in this issue present preclinical data aimed at improving immunotherapeutic approaches for relapsed B- and T-cell acute lymphoblastic leukemia (T-ALL). Chimeric antigen receptor T (CAR-T) cell therapy directed against relapsed T-ALL is hampered by difficulty in identifying a target antigen that is not also expressed on healthy T cells, risking "fratricide" with T-cell aplasia and loss of the CAR-T cells. [...]
2022 - 10.1182/blood.2021014840
Blood, Vol. 140 (july 2022) , p. 38-44  
Detailed record - Creative Commons

See also: similar author names
4 Roberts, I.
1 Roberts, Ian S. D.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with